Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Federal Government Takes Action To Protect American Data

Executive Summary

The Biden administration issued an executive order to protect American data privacy. On the same day, the Senate HELP committee released its report on health data privacy with suggestions to update HIPAA for a modern healthcare world. 

You may also be interested in...



UnitedHealth Group Cyber Attack Disrupts Major Pharmacies For A Week With No End In Sight

Systems from Change Healthcare are experiencing disruptions for the seventh day in a row after a ransomware attack on parent company UnitedHealth Group.

News We’re Watching: Henry Schein Hack, New Codes For Shockwave And Eckso, Breast Implant Safety Update

It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight

AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT154471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel